Walvax Biotechnology H1 Earnings Up 48% - ResearchInChina

Date:2011-08-10hangmei  Text Size:

August 9 – Walvax Biotechnology (RCode:300142) recorded a 48.24-percent year-on-year surge in net profits for the first half of 2011 to 83.85 million yuan, reports p5w.net, citing a company filing. Sale revenues during that period grew 42.64 percent year-on-year to 180 million yuan.

 

2005-2011 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1